Loading
A phase 3 trial of Gamma Tile-Surgically Targeted Radiation Therapy (STaRT) in brain and spinal cord tumours, run by GT Medical Technologies, Inc., active and no longer recruiting.
Post-Surgical Stereotactic Radiotherapy (SRT) Versus GammaTile-ROADS (Radiation One and Done Study) is a phase 3 interventional study registered as NCT04365374 by GT Medical Technologies, Inc., with 230 participants enrolled, started 2021-04-06 and due to reach its primary completion in 2029-08-30. Interventions recorded: Gamma Tile-Surgically Targeted Radiation Therapy (STaRT) and Stereotactic Radiation Therapy.
The full inclusion and exclusion criteria are on the registry record. Read 2026-10-07. Recruiting overall does not mean a particular site is open; ask the study team.
ClinicalTrials.gov data courtesy of the US National Library of Medicine.
Shares GT Medical Technologies and the tag pipeline.
Shares Brain and spinal cord tumours (all types) and the tag pipeline.
Shares Brain and spinal cord tumours (all types) and the tag pipeline.
Shares Brain and spinal cord tumours (all types) and the tag pipeline.
Shares Brain and spinal cord tumours (all types) and the tag pipeline.
Shares Brain and spinal cord tumours (all types) and the tag pipeline.
Shares Brain and spinal cord tumours (all types) and the tag pipeline.
Shares Brain and spinal cord tumours (all types) and the tag pipeline.
Every source this page cites, grouped by who published it. Grouping is read from the web address, not assigned by hand.
A source that has moved or gone is reported by the weekly link check. /audit/